Loading clinical trials...
Loading clinical trials...
Pemetrexed Disodium and Cisplatin Chemotherapy Combined With Synchronous Gefitinib vs Chemotherapy Alone as Adjuvent Therapy in Patient With Stage II-IIIA, Epidermal Growth Factor Receptor Mutant Expressing Lung Adenocarcinoma
Conditions
Interventions
Gefitinib
Pemetrexed
Locations
1
China
Tangdu Hospital of the Fourth Millitary Medical University
Xi'an, Shaanxi, China
Start Date
January 1, 2015
Primary Completion Date
January 1, 2018
Completion Date
January 1, 2020
Last Updated
August 10, 2015
NCT07143110
NCT06885697
NCT04577599
NCT06974604
NCT07035587
NCT04631770
Lead Sponsor
Tang-Du Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions